CNTNAP2 and psychotic disorder: Similarly, in a cohort of patients with first-episode psychosis PANSS scores, cognitive testing and catatonia symptoms were not clinically significant different in anti-neuronal antibody positive (NMDAR, CASPR2, LGI1 or GABAA receptor antibodies) and negative patients [9].